X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Elitecon International Ltd.
BSE CODE: 539533   |   NSE CODE: NA   |   ISIN CODE : INE669R01026   |   14-Aug-2025 Hrs IST
BSE NSE
Rs. 315.50
15 ( 4.99% )
 
Prev Close ( Rs.)
300.50
Open ( Rs.)
315.50
 
High ( Rs.)
315.50
Low ( Rs.)
315.50
 
Volume
30497
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Source DateBoard Meeting DateDetails
04-Aug-2025 12-Aug-2025 Quarterly Results
18-Jul-2025 25-Jul-2025 Inter alia, to consider and approve:- 1. The acquisition of an overseas business entity in accordance with the provisions of the Companies Act, 2013 and other applicable laws, rules and regulations, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Issue of Equity Shares on Preferential basis in accordance with provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013. 3. Shifting of Registered office of the Company from National Capital Territory of Delhi to the State of Maharashtra.
04-Jul-2025 09-Jul-2025 Inter alia, to consider and approve the following business matters: 1. The acquisition of an Overseas business entity in accordance with the provisions of the Companies Act, 2013 and other applicable laws, rules and regulations, as amended, subject to such regulatory/ statutory approvals as may be required. 2. Raising of funds by issue of Equity Shares through Qualified Institutions Placement (?QIP?) for an aggregate amount up to Rs.300,00,00,000/- (Rupees Three Hundred Crores Only) or an equivalent amount thereof (inclusive of such premium or discount as may be fixed on such Equity Shares) subject to the receipt of approval of the Members of the Company and such other approval(s)/ permission(s)/ consent(s)/ sanction(s) of any government/ regulatory/ statutory authorities, as may be required. 3. Issue of Equity Shares on Preferential basis in accordance with provisions of Chapter V of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and other applicable rules, regulations and guidelines of SEBI and applicable provisions of Companies Act, 2013. 4. Any other item with the permission of the Chair
25-Jun-2025 01-Jul-2025 Inter alia, to consider and approve the following business matters: 1. To discuss and evaluate the proposal for raising funds up to an amount of Rs. 75 Crores (Rupees Seventy Five Crores Only) by way of preferential allotment, issue of convertible warrants, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (QIP) or any other permissible instruments/modes, subject to necessary approvals from Shareholders, regulatory bodies and other stakeholders. 2. Any other item with the permission of the Chair.
14-May-2025 27-May-2025 Audited Results
22-Jan-2025 30-Jan-2025 Quarterly Results
09-Jan-2025 16-Jan-2025 Stock Split(Cancelled) & Rights Issue(Cancelled)
14-Nov-2024 20-Nov-2024 Inter alia, to consider and approve the following business matters: 1. Fund raising by way of Issuance of Equity Shares on a preferential basis, subject to the approval of themembers of the Company.
06-Nov-2024 14-Nov-2024 Quarterly Results
02-Sep-2024 04-Sep-2024 Inter alia, to consider and approve: ?The notice calling the Annual General Meeting of the Company. ?The Annual Report for the financial year 2023-24. ?Appointment of Mr. Aakash Goel, Proprietor of G Aakash & Associates, Company Secretaries (Membership No. A57213, CP No.21629) as scrutinizer for the ensuing Annual General Meeting.
Page 1 of 6
PREV || NEXT